In anticipation of the imminent commercialization of the Kaleido insulin delivery system, the ViCentra Board is announcing today a change in management that prepares the Company for the next phase in its future.
Joseph Cefai stepped down as CEO on April 1st, 2016. Joseph will take up the role of Special Advisor to the Board and will initially support the Board with the transition to the new management team.
ViCentra Board management change
In announcing this change, the Board at ViCentra wanted to recognize the excellent work that Joseph has done in building ViCentra. Joseph is the inventor of the Kaleido core technology, the driving force that founded ViCentra, and was instrumental in galvanizing the team around the development of this exciting and groundbreaking product and securing CE marking in September 2015. They applaud both the speed and efficiency with which this has been achieved and the value it has created for its shareholders. The Board also recognizes the unique culture Joseph has brought to the ViCentra family creating an environment in which commitment and dedication thrived. They are confident the Company will capitalize on this great work when the product enters the market.
The Board at ViCentra is looking forward to continuing to work with Joseph in his new capacity as Special Advisor to the Board and looks forward to his continuing influence on the direction of the Company and the Kaleido insulin delivery system.